Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving the Population-Wide Effectiveness of U.S. Tobacco Cessation Quitlines
Brief Summary: Research shows that smoking cessation is the most significant preventable health behavior change that a person can make to lower cancer risk. In addition, telephone quitlines are an effective, science-based smoking cessation treatment that is universally accessible to smokers in the U.S. However, little research has explored promising approaches that could increase quitline use, improve quit rates, and inform resource allocation for quitline services. The proposed study will test three promising enhancements to the standard quitline treatment that typically consists of counseling and, possibly 2 weeks of a NRT medication. These enhancements are: 1) combination nicotine replacement therapy as recommended by the United States Public Health Service Clinical Practice Guideline on Treating Tobacco Use and Dependence; 2) extended duration of cessation medication use; and 3) an innovative counseling addition - cognitive medication adherence counseling - to optimize adherence to cessation medication. In addition, the cost-effectiveness of each intervention will be calculated. The findings of the proposed research have broad potential application and relevance to state quitlines, quitline service providers, and other purchasers of quitline services such as employers and insurers. Additionally, the study findings can potentially inform other telephone health behavior counseling programs.


Options:
A: Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Control | Arm Label: Acceptance and Commitment Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Acceptance and Commitment Therapy | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control | Intervention Type: BEHAVIORAL; Name: Acceptance and Commitment Therapy; Assigned to Arm(s): Acceptance and Commitment Therapy
B: Arm Label: 2 Weeks of Nicotine Patch Only, No CMAC; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nicotine patch | Arm Label: 2 Weeks of Nicotine Patch Only plus CMAC; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nicotine patch, Behavioral: CMAC | Arm Label: 2 Wks Nicotine Patch+Nic Gum, No CMAC; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nicotine patch, Drug: Nicotine gum | Arm Label: 2 Wks Nicotine Patch+Nic Gum plus CMAC; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nicotine patch, Drug: Nicotine gum, Behavioral: CMAC | Arm Label: 6 Weeks of Nicotine Patch Only, No CMAC; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nicotine patch | Arm Label: 6 Weeks of Nicotine Patch Only plus CMAC; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nicotine patch, Behavioral: CMAC | Arm Label: 6 Wks Nicotine Patch+Nic Gum, No CMAC; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nicotine patch, Drug: Nicotine gum | Arm Label: 6 Wks Nicotine Patch+Nic Gum plus CMAC; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nicotine patch, Drug: Nicotine gum, Behavioral: CMAC | Intervention Type: DRUG; Name: Nicotine patch; Assigned to Arm(s): 2 Weeks of Nicotine Patch Only plus CMAC, 2 Weeks of Nicotine Patch Only, No CMAC, 2 Wks Nicotine Patch+Nic Gum plus CMAC, 2 Wks Nicotine Patch+Nic Gum, No CMAC, 6 Weeks of Nicotine Patch Only plus CMAC, 6 Weeks of Nicotine Patch Only, No CMAC, 6 Wks Nicotine Patch+Nic Gum plus CMAC, 6 Wks Nicotine Patch+Nic Gum, No CMAC | Intervention Type: DRUG; Name: Nicotine gum; Assigned to Arm(s): 2 Wks Nicotine Patch+Nic Gum plus CMAC, 2 Wks Nicotine Patch+Nic Gum, No CMAC, 6 Wks Nicotine Patch+Nic Gum plus CMAC, 6 Wks Nicotine Patch+Nic Gum, No CMAC | Intervention Type: BEHAVIORAL; Name: CMAC; Assigned to Arm(s): 2 Weeks of Nicotine Patch Only plus CMAC, 2 Wks Nicotine Patch+Nic Gum plus CMAC, 6 Weeks of Nicotine Patch Only plus CMAC, 6 Wks Nicotine Patch+Nic Gum plus CMAC
C: Arm Label: High intensity disease management; Type: EXPERIMENTAL; Interventions: Behavioral: High intensity disease management, Drug: Bupropion | Arm Label: Low intensity disease management; Type: EXPERIMENTAL; Interventions: Behavioral: Low intensity disease management, Drug: Bupropion | Arm Label: Comparison group; Type: OTHER; Interventions: Behavioral: Comparison group, Drug: Bupropion | Intervention Type: BEHAVIORAL; Name: High intensity disease management; Assigned to Arm(s): High intensity disease management | Intervention Type: BEHAVIORAL; Name: Low intensity disease management; Assigned to Arm(s): Low intensity disease management | Intervention Type: BEHAVIORAL; Name: Comparison group; Assigned to Arm(s): Comparison group | Intervention Type: DRUG; Name: Bupropion; Assigned to Arm(s): Comparison group, High intensity disease management, Low intensity disease management
D: Arm Label: Materials; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-help materials | Arm Label: Telephone Counseling and Materials; Type: EXPERIMENTAL; Interventions: Behavioral: Telephone counseling, Behavioral: Self-help materials | Intervention Type: BEHAVIORAL; Name: Telephone counseling; Assigned to Arm(s): Telephone Counseling and Materials | Intervention Type: BEHAVIORAL; Name: Self-help materials; Assigned to Arm(s): Materials, Telephone Counseling and Materials

Answer: B